Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies

By He Lufen   Zhou Lu   Wang Taijin   Li Zicheng   Tang Xiangyang  

Molecular Simulation, Vol. 39, Iss. 8, 2013-07 ,pp. : 640-652

Taylor & Francis Ltd

Access to resources Recommend Favorite

3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA

By Wang Rong Wei   Zhou Lu   Zuo Zhili   Ma Xiang   Yang Min  

Molecular Simulation, Vol. 36, Iss. 2, 2010-02 ,pp. : 87-110

Taylor & Francis Ltd

Access to resources Recommend Favorite

Molecular docking-based 3D-QSAR studies of pyrrolo[3,4-c]pyrazole derivatives as Aurora-A inhibitors

By He G.   Qiu M. H.   Li R.   Song X. R.   Zheng X.   Shi J. Y.   Xu G. B.   Han J.   Yu L. T.   Yang S. Y.   Chen L. J.   Wei Y. Q.  

Molecular Simulation, Vol. 37, Iss. 1, 2011-01 ,pp. : 31-42

Taylor & Francis Ltd

Access to resources Recommend Favorite

A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors

By Maluf Fernando V   Andricopulo Adriano D   Oliva Glaucius   Guido Rafael VC  

Future Medicinal Chemistry, Vol. 5, Iss. 17, 2013-11 ,pp. : 2019-2035

Future Science

Access to resources Recommend Favorite

Discovery of novel 5α-reductase type II inhibitors by pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulations

By Wang Jhih-Lun   Liu Hsuan-Liang   Zhou Zheng-Li   Chen Wei-Hsi   Ho Yih  

Molecular Simulation, Vol. 41, Iss. 4, 2015-03 ,pp. : 287-297

Taylor & Francis Ltd

Access to resources Recommend Favorite